Lung disease continues to be the major cause of morbidity and mortality in cystic fibrosis (CF). Gene transfer offers the potential to express the cystic fibrosis transmembrane conductance regulator (CFTR) in the lungs of people with cystic fibrosis (CF) and thereby prevent or treat lung disease. But, we lack answers to many questions that are crucial for developing gene transfer. A major impediment to progress has been lack of animal models with disease that mimics human CF. To overcome this roadblock, we developed a porcine model of CF that spontaneously develops lung disease. We discovered that loss of CFTR impairs the activity of antimicrobials in airway surface liquid (ASL) and hinders mucociliary transport (MCT). In both cases, loss of CFTR-mediated bicarbonate secretion and an abnormally acidic pH are key factors. We also developed novel assays of these host defense mechanisms for both in vitro and in vivo experiments. We will use this novel model and assays to answer questions that are key for advancing CF treatments. First, How does CFTR expression level and the fraction of cells expressing CFTR affect airway epithelial ion transport and host defense processes? Answering this question will for the first time provide key data about relationships between specific CFTR functions and host defense. Second, will CFTR expression correct host defense defects and prevent and/or treat CF lung disease in vivo? We will develop CF pigs with inducible expression of CFTR in epithelia and test the hypotheses a) that expressing CFTR in airways rescues host defense processes, b) that CFTR expression beginning shortly after birth prevents airway infection, inflammation and remodeling, c) that expressing less than wild-type levels of CFTR in airway epithelia is sufficient to prevent lung disease, and d) that CFTR expression after disease onset treats or reverses airway disease. Third, will expressing CFTR in ciliated cells rescue host defense defects and prevent clinical CF lung disease? If ciliated cell expression prevents lung disease, it will mark ciliated cells as a key target for gene transfer. If not, the data will guide studies that identify key therapeutic targets. Results from this work and synergism with Projects 1 & 3 will inform strategies for gene transfer and other therapies.

Public Health Relevance

Gene transfer offers the potential to express CFTR in the airways of people with cystic fibrosis and thereby prevent, slow, or reverse the lung disease. However, lack of animal models that replicate the human disease has prevented scientists from answering many questions that are crucial for developing gene transfer. Here we use a novel porcine model of CF to answer, for the first time, questions about how much, when and where CFTR expression is required to reverse cystic fibrosis host defense defects and rescue the clinical lung disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Lachowicz-Scroggins, Marrah Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Iowa City
United States
Zip Code
Meyerholz, David K; Sieren, Jessica C; Beck, Amanda P et al. (2018) Approaches to Evaluate Lung Inflammation in Translational Research. Vet Pathol 55:42-52
Rosen, Bradley H; Evans, T Idil Apak; Moll, Shashanna R et al. (2018) Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets. Am J Respir Crit Care Med 197:1308-1318
Mao, Suifang; Shah, Alok S; Moninger, Thomas O et al. (2018) Motile cilia of human airway epithelia contain hedgehog signaling components that mediate noncanonical hedgehog signaling. Proc Natl Acad Sci U S A 115:1370-1375
Montoro, Daniel T; Haber, Adam L; Biton, Moshe et al. (2018) A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature 560:319-324
Lynch, Thomas J; Anderson, Preston J; Rotti, Pavana G et al. (2018) Submucosal Gland Myoepithelial Cells Are Reserve Stem Cells That Can Regenerate Mouse Tracheal Epithelium. Cell Stem Cell 22:653-667.e5
Meyerholz, David K; Stoltz, David A; Gansemer, Nick D et al. (2018) Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs. Lab Invest 98:825-838
Gray, Robert D; Hardisty, Gareth; Regan, Kate H et al. (2018) Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis. Thorax 73:134-144
Thornell, Ian M; Li, Xiaopeng; Tang, Xiao Xiao et al. (2018) Nominal carbonic anhydrase activity minimizes airway-surface liquid pH changes during breathing. Physiol Rep 6:
Reznikov, Leah R; Meyerholz, David K; Abou Alaiwa, Mahmoud et al. (2018) The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol 315:L133-L148
Meyerholz, David K; Beck, Amanda P; Goeken, J Adam et al. (2018) Glycogen depletion can increase the specificity of mucin detection in airway tissues. BMC Res Notes 11:763

Showing the most recent 10 out of 184 publications